About AccuLine
AccuLine is a company based in Israel founded in 2022 by Benny Shani, Moshe Barel, Shai Revzen, and Aaron Frimerman. AccuLine has raised $4.2 million across 2 funding rounds from investors including Mayo Clinic, Maccabi Health Services and eHealth Ventures. AccuLine offers products and services including CORA. AccuLine operates in a competitive market with competitors including Cardiac Insight, LifeLens, BaroPace, MindRhythm and Tianyi Hexin, among others.
- Headquarter Israel
- Founders Benny Shani, Moshe Barel, Shai Revzen, Aaron Frimerman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.2 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Mayo Clinic
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AccuLine
AccuLine offers a comprehensive portfolio of products and services, including CORA.
Assesses coronary artery disease risk using AI and vital signs quickly.
Funding Insights of AccuLine
AccuLine has successfully raised a total of $4.2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AccuLine
AccuLine has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, Maccabi Health Services and eHealth Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage digital health ventures are funded and supported.
|
Locked | Locked | Locked | |
|
Membership-based healthcare services are offered for discovery and management.
|
Locked | Locked | Locked | |
|
General medical clinics are operated throughout the United States.
|
Locked | Locked | Locked |
Investor details for AccuLine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AccuLine
Investment portfolio details for AccuLine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AccuLine
Detailed financials for AccuLine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acculine Comparisons
Peer comparison for AccuLine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AccuLine
AccuLine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiac Insight, LifeLens, BaroPace, MindRhythm and Tianyi Hexin, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Point-of-care cardiac diagnostics are provided for sports medicine.
|
|
| Locked | Locked | Locked |
Developer of a device for cardiac health monitoring
|
|
| Locked | Locked | Locked |
Smart wearable devices for cardiac health monitoring are developed.
|
|
| Locked | Locked | Locked |
Provider of a medical diagnostic medical device for stroke management
|
|
| Locked | Locked | Locked |
Diagnostic sensors and electronic chips are manufactured for various applications.
|
Detailed competitors of AccuLine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acculine
Complete news archive for AccuLine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccuLine
AccuLine was founded in 2022 and raised its 1st funding round 2 years after it was founded.
AccuLine is headquartered in Israel.
Moshe Barel is the current CEO of AccuLine. They have also founded this company.
AccuLine is a funded company, having raised a total of $4.2M across 2 funding rounds to date.
AccuLine was founded in 2022 in Israel within the medical technology sector. A smart diagnostic device named CORA is being developed, incorporating machine-learning algorithms to enable early detection of coronary artery disease. Operations focus on advancing non-invasive health diagnostics, with core activities centered in device innovation and clinical application testing. The companys efforts are directed toward improving cardiovascular screening accessibility in healthcare settings.
AccuLine's top competitors include Cardiac Insight, MindRhythm and LifeLens.
AccuLine offers CORA.
AccuLine has 3 investors. Key investors include Mayo Clinic, Maccabi Health Services, and eHealth Ventures.